Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001746473-24-000063

Chief Financial Officer acquired 21,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cummings Keith Lamont Chief Financial Officer 2024-05-02 Option exercise +21,000 $2.08 $43,680 271,713 D
Derivatives
Cummings Keith Lamont Chief Financial Officer 2024-05-02 Option exercise · Stock Option (Right to Buy) −21,000 76,047 D
Loading xslF345X05/wk-form4_1714989755.xml…